Skip to main content
NIH funding notice RFA-DK-19-008

Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)

Closed on November 7, 2019.

Posted
May 29, 2019
Close date
November 7, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $677,982 in first-year total cost, median $677,982.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (M1)]1

Most frequent institutions

  1. UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
Competing awards under RFA-DK-19-008 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Metabolic impact of FGF-21 in adipose tissue and liver of PLWH1R01DK126042-01LAKE, JORDAN EUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$677,982ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-19-008: Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional) | ScienceDex | ConductScience